References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN
2008 v2.0, Cancer incidence and mortality world-wide: IARC CancerBase No. 10
[Internet]. Lyon, France: Inter-national Agency for Research on Cancer; 2010.
Available from: http://globocan.iarc.fr [accessed 12/07/2012].
3. Jensen OM, Este`ve J, Møller H, Renard H. Cancer in the European
Community and its member states. Eur J Cancer 1990;26:1167–256.
4. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality
in the European Union: cancer registry data and estimates of national incidence
for 1990. Eur
J Cancer 1997;33:1075–107.
5. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence
and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.
6.
Boyle P, Ferlay J. Cancer incidence and
mortality in Europe, 2004. Ann Oncol 2005;16(3):481–8.
7. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Cancer
incidence and mortality in Europe, 2006. Ann Oncol 2007;16(3):481–8.
8. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer
incidence and mortality in Europe in 2008. Eur J Cancer 2010;46(4):765–81.
9.
World Health Organization (WHO) Databank.
Geneva, Switzer-land: WHO Statistical Information System. Available from: < http://www.who.int/whosis> [accessed July 2012].
10. Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Comber H,
Bray F. European cancer observatory: cancer incidence, mortality, prevalence
and survival in Europe. Version 1.0 (September 2012) European Network of Cancer
Registries, International Agency for Research on Cancer. Available from: http://eco.iarc.fr [accessed 14/09/2012].
11. World Health Organization. International statistical classification
of diseases and related health problems. Tenth revision, vol. 2. Geneva,
Switzerland: WHO; 1993.
13. Dyba T, Hakulinen T. Comparison of different approaches to incidence
prediction based on simple interpolation techniques. Stat
Med 2000;19(13):1741–52.
14.
Projection de l’incidence et de la mortalite´
par cancer en France en 2011. Rapport technique. Saint-Maurice: Institut de
veille sani-taire; 2011. p. 78. Available from: http://www.invs.sante.fr>.
15. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a
technical report. Berlin, Germany: Springer-Verlag (for UICC); 1966.
16. Cancer registry Federation of Bosnia and Herzegovina. Overview of
malignant neoplasms 2009. Institute for Public Health of Federation of Bosnia
and Herzegovina, 2011.
J.
Ferlay et al. / European Journal of Cancer 49 (2013) 1374–1403
|
1403
|
17. Lutz JM, Pury P, Fioretta G, Raymond L. The impact of coding process
on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 2004;13(1):77–81.
18. Pavillon G, Boileau J, Renaud G, et al. Conse´quences des changements
de codage des causes me´dicales de de´ce`s sur les donne´es nationales de
mortalite´ en France, a` partir de l’anne´e 2000. Bull
Epidemiol Hebd 2005;4:13–6.
19. Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep
and goats: separating cervix and corpus uteri from imprecisely coded uterine
cancer deaths, for studies of geographical and temporal variations in
mortality. Eur J Cancer 2004;40:2794–803.
20. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia
R. EUROCARE-4. Survival of cancer patients diag-nosed in 1995–1999. Results and
commentary, the EUROCARE Working Group. Eur J Cancer 2009;45:931–91.
21. Cancer in Ukraine 2009-2010. Bulletin of National Cancer Registry of
Ukraine No. 12. Kiev; 2011. Available from: http://
users.iptelecom.net.ua/~ucr/ [accessed 03-07-2012].
22.
Swiss Federal Statistical Office. Cause of death
statistics FSO – The Statistical Encyclopedia.
23. Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence,
mortality, prevalence and survival in the nordic countries, version 5.1 (March 2012).
Association of the Nordic Cancer Registries. Danish Cancer Society. Available
from http:// www.ancr.nu
[accessed 11/06/2012.
24. Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five
continents, volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France:
International Agency for Research on Cancer; 2010. Available from: http://ci5.iarc.fr.
25. Curado MP, Edwards B, Shin HR, et al. (Eds.), Cancer incidence in
five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: IARC;
2007.
26. Finnish Cancer Registry. Cancer in Finland 2008 and 2009. Cancer
Society of Finland Publication No. 84, Helsinki; 2011.
27. Registre Morphologique des Tumeurs au Grand – Duche´ de Luxembourg.
Available from: http://www.cancer-registry.lu [accessed 25/06/2012].
28. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European
cancer mortality predictions for the year 2012. Ann Oncol 2012;23(4):1044–52, Epub 2012 Feb 28.
29. International Agency for Research on Cancer (IARC). Mono-graphs on
the evaluation of carcinogenic risks to humans, vol 83. Tobacco smoke and
involuntary smoking. Lyon, France: IARC; 2004.
30.
Bray F, Weiderpass E. Lung cancer mortality
trends in 36 European countries: secular trends and birth cohort patterns by
sex and region 1970–2007. Int
J Cancer 2010;126(6):1454–66.
31.
Soerjomataram I, de Vries E, Pukkala E, Coebergh
JW. Excess of cancers in Europe: a study of eleven major cancers amenable to
lifestyle change. Int
J Cancer 2007;120(6):1336–43.
32.
World Cancer Research Fund. Food, nutrition and
the prevention of cancer: a global perspective.
Washington: World Cancer Research Fund/American Institute for
Cancer Research; 1997.
33. Segnan N, Patnick J, von Karsa L, editors. European
guidelines for quality assurance in colorectal
cancer screening and diagnosis. 1st ed. Luxembourg: European Commission, Publications Office of the
European Union; 2010.
34. Soerjomataram I, Pukkala E, Brenner H, Coebergh JW. On the
avoidability of breast cancer in industrialized societies: older mean age at
first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 2008;111(2):297–302, Epub 2007 Oct 12.
35. He´ry C, Ferlay J, Boniol M, Autier P. Quantification of changes in
breast cancer incidence and mortality since 1990 in 35 countries with
Caucasian-majority populations. Ann Oncol
2008;19(6):1187–94.
36. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S,
Coebergh JW. Recent trends of cancer in Europe: a combined approach of
incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J
Cancer 2008;44(10):1345–89.
37. Moss SM, Nystro¨m L, Jonsson H, et al. The impact of mammographic
screening on breast cancer mortality in Europe: a review of trend studies. J Med
Screen 2012:19.
38.
Bray F, Lortet-Tieulent J, Ferlay J, Forman D,
Auvinen A. Prostate cancer incidence and mortality trends in 37 European
countries: an overview. Eur
J Cancer 2010;46(17):3040–52.
39. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation
to diet, physical activity, and body size in blacks, whites, and Asians in the
United States and Canada. J Natl Cancer Inst 1995;87:652–61.
40. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting
trends in prostate cancer – part II: cause of death misclassification and the
recent rise and fall in prostate cancer mortality. J Natl
Cancer Inst 1999;16:91(12):1025–32.
41. Hakulinen T, Arbyn M, Brewster DH, et al. Harmonization may be
counterproductive – at least for parts of Europe where public health research
operates effectively. Eur J Public Health 2011;21(6):686–7, Epub 2011 Nov
10.